Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jul;137(1):126-9.
doi: 10.1016/j.otohns.2007.01.015.

Malignant head and neck paragangliomas in SDHB mutation carriers

Carsten Christof Boedeker  1 , Hartmut P H Neumann, Wolfgang Maier, Birke Bausch, Jörg Schipper, Gerd Jürgen Ridder
Affiliations

Malignant head and neck paragangliomas in SDHB mutation carriers

Carsten Christof Boedeker et al. Otolaryngol Head Neck Surg. 2007 Jul.

Abstract

Objective: Three of four paraganglioma syndromes (PGLs) have been characterized on a molecular genetic basis. PGL 1 is associated with mutations of the succinate dehydrogenase subunit D (SDHD) gene, PGL 3 is caused by SDHC gene mutations, and PGL 4 is caused by SDHB gene mutations. The objective of this study was to investigate whether PGLs are associated with malignant head and neck paragangliomas (HNPs).

Study design and setting: Through November 2005, we screened 195 HNP patients for mutations of the genes SDHB, SDHC, and SDHD.

Results: We detected 5 SDHC, 13 SDHB, and 45 SDHD gene mutations. In seven SDHB mutation carriers, there were distant metastases. No signs of metastases were found in SDHC and SDHD patients. One patient with a sporadic HNP presented with locally metastatic disease.

Conclusions: SDHB mutations are associated with a high rate of malignant HNPs.

Significance: In SDHB patients, a three-body region imaging and scintigraphy or DOPA-PET must be performed to exclude metastases.

PubMed Disclaimer

MeSH terms